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Abstract: Recessive loss-of-function variants in SLC39A13, a putative zinc transporter gene, were
first associated with a connective tissue disorder that is now called “Ehlers–Danlos syndrome,
spondylodysplastic form type 3” (SCD-EDS, OMIM 612350) in 2008. Nine individuals have been
described. We describe here four additional affected individuals from three consanguineous families
and the follow up of two of the original cases. In our series, cardinal findings included thin and finely
wrinkled skin of the hands and feet, characteristic facial features with downslanting palpebral fissures,
mild hypertelorism, prominent eyes with a paucity of periorbital fat, blueish sclerae, microdontia,
or oligodontia, and—in contrast to most types of Ehlers–Danlos syndrome—significant short stature
of childhood onset. Mild radiographic changes were observed, among which platyspondyly is a
useful diagnostic feature. Two of our patients developed severe keratoconus, and two suffered from
cerebrovascular accidents in their twenties, suggesting that there may be a vascular component
to this condition. All patients tested had a significantly reduced ratio of the two collagen-derived
crosslink derivates, pyridinoline-to-deoxypyridinoline, in urine, suggesting that this simple test
is diagnostically useful. Additionally, analysis of the facial features of affected individuals by
DeepGestalt technology confirmed their specificity and may be sufficient to suggest the diagnosis
directly. Given that the clinical presentation in childhood consists mainly of short stature and
characteristic facial features, the differential diagnosis is not necessarily that of a connective tissue
disorder and therefore, we propose that SLC39A13 is included in gene panels designed to address
dysmorphism and short stature. This approach may result in more efficient diagnosis.
Keywords: Ehlers–Danlos syndrome; SLC39A13; dysmorphology; short stature; connective tissue;
DeepGestalt technology
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1. Introduction
The Ehlers–Danlos syndrome (EDS) is a group of disorders that affect connective tissues in the
skin, ligaments, joints, blood vessels, and other organs. Defects in connective tissue cause a wide
range of clinical manifestations, from mildly loose joints to life-threatening conditions, such as arterial
bleeds. From the original description as a disorder of hyperelastic skin and lax joints at the beginning
of the 20th century [1], a first classification with four main types was proposed in 1970 [2]; molecular
advances have allowed the recognition of many distinct disorders that, although different from the
classic EDS types described by Beighton, have been given the moniker of “Ehlers–Danlos syndrome” as
a reflection of the presence of connective tissue fragility. Thus, the recent version of EDS classification
has been expanded to include a wide range of disorders, including skeletal dysplasia [3]. However, the
clinical criteria remain relatively non-specific, and clinical diagnosis can be difficult.
A connective tissue disorder associated with recessive biallelic variants in SLC39A13, and a
mouse knock-out model for the same gene, were described in 2008 by two separate but collaborating
groups [4,5]. The features noted in these eight patients were postnatal-onset short stature, protuberant
eyes with bluish sclerae and down-slanting palpebral fissures, thin and moderately hyperelastic skin
with bruisability, and hands with finely wrinkled palms, tapering fingers, thenar atrophy, and moderate
hypermobility of the small joints. Skeletal radiographs showed a moderate degree of platyspondyly
with irregular vertebral end plates as well as minor epimetaphyseal changes in appendicular bones.
A reduced molar ratio of pyridinoline-to-deoxypyridinoline in urine was observed, indicating reduced
collagen lysyl hydroxylation. The latter finding is typically observed in collagen lysyl hydroxylase
deficiency (EDS type VI-A), but in that condition, there is severe muscular hypotonia from birth,
progressive kyphoscoliosis, and normal height (apart from kyphoscoliosis). Additionally, there were no
pathogenic mutations in PLOD1; instead, the patients reported by Giunta et al. (2008) were homozygous
for an in-frame 9-bp deletion in SLC39A13, c.483_491del (p.F162_164del), while those reported by
Fukada et al. (2008) were homozygous for the SLC39A13 variant c.221G>A (p.G74D). The novel
condition was given the name of “spondylo-cheiro-dysplastic EDS” for the distinguishing features of
the hand and the platyspondyly [4,5]. Later, the EDS nosology has used the name “spondylodysplastic
EDS” for a group of three conditions, B3GALT6 deficiency (better known as spondyloepimetaphyseal
dysplasia with joint laxity, Beighton type), B4GALT7 deficiency, and SLC39A13 deficiency (the original
spondylo-cheiro-dysplastic type) [3]. Of note, these three conditions are also included in the 2019
revision of the skeletal dysplasia nosology [6]. SLC39A13 deficiency is rare and following the initial
eight affected individuals, only a single case report has been published [7]. We present a follow up
of two of the original patients [5] as well as clinical, radiological, and genetic findings on four new
patients from three families.
2. Materials and Methods
All affected individuals and/or their legal representatives in the study gave their informed consent
to the use of their clinical data, as well as for molecular studies in a diagnostic context (see below).
2.1. Molecular Analysis
Molecular studies for patients 1 and 2 were done in the Lausanne laboratory as described [5].
Molecular studies in patients 3 to 6 were done for diagnostic purposes with appropriate informed
consent from patients and their guardians. The studies were done using routine diagnostic sequencing
procedures in certified diagnostic laboratories: Analysis for patients 3, 5, and 6 was done in Lausanne,
while the analysis of patient 4 was done in Nijmegen.
2.2. Analysis of Pyridinium Crosslink Products by HPLC
Spot urine samples were acid hydrolyzed and analyzed by reverse-phase HPLC as previously
described [4].
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2.3. Analysis of Facial Features
Anonymized frontal facial photographs of individuals with confirmed biallelic SLC39A13 variants
were used to capture the facial gestalt of SLC39A13 deficiency and to compare it to individuals who
are clinically normal. All images were fully de-identified through the use of the DeepGestalt image
analysis technology [8]. De-identified data of images from 8 patients (the six patients reported here,
plus two of the patients described by Giunta et al. (2008) whose photographs had been submitted to us
for clinical consultation) were uploaded to the Face2Gene Research app [9] and matched to controls by
age, sex, and ethnicity to produce artificial composite images. Because of the small number of patients,
the comparison was run twice [10] with two different sets of matched controls. The comparison
and separation quality between the three groups was evaluated by measuring the area under the
curve (AUC) of the receiver operating characteristic (ROC) curve. To estimate the statistical power
of DeepGestalt in distinguishing affected individuals from controls, a cross-validation scheme was
used, including a series of binary comparisons between all groups. For these binary comparisons, the
data was split randomly multiple times into training sets and test sets. Each such set contained half of
the samples from the group, and this random process was repeated 10 times [8,10]. The results of the
binary comparisons were reported both numerically and graphically.
2.4. Clinical Reports
2.4.1. Individuals 1 and 2 (reported in part by Fukada et al., 2008 [5])
The parents, of Portuguese origin, were of average stature and clinically unremarkable. They were
not knowingly related, although molecular workup showed that they shared a common haplotype
harboring the SLC39A13 pathogenic variant [5]. The affected children, a boy and a girl, were born
at term from uncomplicated pregnancies and were of normal size and weight at birth but showed
progressive short stature beginning in the second half of the first year of life. Among the clinical
signs in early childhood were muscular hypotonia and soft skin, leading to the diagnostic suspicion
of the Ehlers–Danlos syndrome (EDS). During childhood, the main clinical signs and features were
thin, fragile, but not hyperelastic skin that bruised easily and was particularly thin on the hands and
feet; varicose veins; moderate joint laxity; blueish or greyish sclerae; down-slanting palpebral fissures;
and the absence of one or more teeth in permanent dentition. Both had astigmatism in childhood.
Radiographic examination revealed moderate osteopenia, flattened or biconcave vertebral bodies with
flaky irregularity of the endplates as well as mild dysplastic changes at the metaphyses of long bones
and of the phalanges. At the time of the first report, they were 28 years old and 145 cm tall (individual
1, male); and 20 years old and 135 cm tall (individual 2, female). Their body proportions were normal,
indicating that the platyspondyly was accompanied by shortening of the long bones. Their skin
remained thin and fragile, and the subcutaneous fat tissue was sparse. Both individuals had marked
venous varicosities on their legs and feet. Individual 1 suffered from a cerebral hemorrhage posteriorly
to the left putamen at age 22 years, from which he recovered completely. He has successfully completed
higher education.
Subsequent to the initial publication in 2008, individual 1 has had no further complications;
he is professionally active, has married, and his wife has given birth to a healthy child. Individual
2, his younger sister, had obtained higher education degrees at age 22 and 25 years. At age 25 years,
cerebral vascular imaging was obtained, and no abnormalities were observed. At age 26 years, two
weeks after the interruption of hormonal contraception prescribed because of irregular cycles, she
suffered from arterial thromboembolism that caused cerebral ischemia with right arm paresis and
Broca’s aphasia. Several days after initiation of aspirin therapy, she developed cerebral hemorrhage
leading to complete right hemiparesis. Fortunately, she was able to partially recover over four years
on physiotherapy but still has partial function of the right hand and myoclonus on the right arm.
She received speech/language therapy; however, she still has some degree of dysphasia. Nevertheless,
she was able to return to her previous work.
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2.4.2. Individual 3
This is a girl born by caesarean section at 33 weeks of gestation from a dizygotic twin pregnancy.
Both the patient and her twin sister were 2500 g at birth. The patient developed progressive short stature
over her first years of life, while her twin sister grew normally. Motor and intellectual development
were normal. The parents are first cousins of Turkish origin and measure 148 cm and 170 cm with
normal proportions. An elder brother had normal growth and body proportions. During her teenage
years, she developed severe keratoconus with no complications so far. She complains about back
pain and her skin bruises easily, with hematomas and blood blisters at sites of friction. Radiographic
examination of the spine at age 15 revealed platyspondyly of the thoracic and lumbar vertebrae with
mild anterior beaking. On physical examination at age 23, she had short stature. There was moderate
diffuse joint laxity most marked on the finger joints. The skin on her hands is thin and wrinkled and
she has tapering fingers with narrow end phalanges. Facial features include downslanting palpebral
fissures, a flat face, protuberant eyes with reduced periocular tissue, greyish sclerae, and a small mouth.
2.4.3. Individual 4
This boy was the fourth child from healthy parents of Turkish descent. The parents were second
cousins and measured 165 cm (father) and 158 cm (mother). His three older sibs have normal growth.
He was born after an uneventful term pregnancy with a birthweight of 3500g. He developed progressive
short stature over his first years of life and was first seen by a pediatrician at age 8 1/2 years. Height
was 113.4cm (−3.8 SDS) and weight was 23.5kg (−1.5 SDS). Psychomotor development was normal.
He complained of knee and ankle pain after exercise. He had mild weakness of the hands, making
it difficult to open bottles. He had no clear dysmorphic features, but his palpebral fissures were
down-slanting and he had oligodontia (missing five teeth). He has had no eye complication so far.
He had a short trunk and stands with lumbar hyperlordosis. He had loose skin on hands and feet,
moderate hyperlaxity of fingers and toes, valgus deformity of the ankles, and bilateral pes planus.
Radiological examination showed platyspondyly of the thoracic and lumbar spine with mild anterior
beaking and mild metaphyseal irregularities especially of the distal ulna. He first received a clinical
diagnosis of spondylometaphyseal dysplasia. Molecular analysis of SHOX, FGFR3, TRPV4, and
LTBP3 were negative, but further studies showed a biallelic missense change in SLC39A13 (Table 1).
Additional urine analysis showed a low ratio of pyridinoline-to-deoxypyridinoline (Figure 3).
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Table 1. Overview of the molecular results.




c.483_491delCTTCCTGGC c.793G>A/c.793G>A c.1019delT/c.1019delT c.1019delT/c.1019delT
Protein
(NP_001121697.2) p.Gly74Asp p.Gly74Asp p.Phe162Ala164del p.Asp265Asn p.Leu340ProfsTer23 p.Leu340ProfsTer23
Frequency in
gnomAD ** absent absent
extremely low, AF =




pathogenic pathogenic pathogenic pathogenic pathogenic pathogenic
Notes: * these two siblings have been reported by us before (Fukada et al., 2008); ** as assessed in March 2020 on the gnomAD database (https://gnomad.broadinstitute.org/); *** as assessed
in March 2020 on the VARSOME integrative website (https://varsome.com/).
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2.4.4. Individuals 5 and 6
The family originates from Syria and access to early medical records is impossible. The parents,
who are first cousins, are clinically healthy and measure 150 cm in height (mother) and 160 cm (father).
The proband (patient 6; Figure 1) is a 9-year-old boy referred for evaluation for small stature. We found
that his elder sister is similarly affected (patient 5), while a younger sister is clinically normal. Individual
6 was born at term after an uneventful pregnancy, although IUGR was noted and the mother reports
reduced fetal movements throughout the pregnancy. Birth data were not recorded, but the mother
remembers his length to be reduced. At birth, the mother noted the he had no spontaneous movements,
had edema on both feet, and increased palmar creases on his hands and feet. Throughout childhood,
psychomotor development was slightly delayed, but intelligence and behavior at age 9 years were
normal. At this age, his growth parameters were height 111 cm (−3.9 SD), weight 19 kg (−3.3 SD),
and head circumference 51.5 cm (−0.78 SD). He had down-slanting palpebral fissures, protruding
eyes, hypertelorism, and a large forehead. An ophthalmologic evaluation revealed bilateral myopia
and marked keratoconus. Hearing was normal. Four teeth of the permanent dentition were found
to be missing. His elbow joints appeared prominent, but he had no other signs of joint deformity or
scoliosis. He had hyperlaxity of small joints and complained occasionally of joint pain particularly
in his knees. The skin was thin and wrinkled, particularly on the palmar side of his hands and feet,
and the thenar muscles were underdeveloped. Radiographic studies showed small epiphyses and
posterior subluxation of the radii and mild platyspondyly. Routine blood tests were unremarkable.
Analysis of SHOX done prior to referral was negative.
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Figure 1. Clinical and radiographic findings. Individuals 5 (panels A and B) and 6 (panels A and
C) at the age of eight and ten years. Panels D and E: missing upper incisives, and missing lower
incisives with persistence of primary teeth in individuals 6 at age 9 years. Panel F: foot of individual 6
showing finely wrinkled skin and abnormally deep furrows. Panel G: Palmar aspects of the hands
of individual 5 showing thin skin with increased number of fine wrinkles and mild thenar and
hypothenar atrophy. Panel H shows the hand radiograph of individual 5 at age ten years. There is
mild diaphyseal overconstriction of radius and ulna, metacarpals, and phalanges; bone maturation is
roughly appropriate; overall, the changes are mild and non-diagnostic. Panels I and K: lateral spine
radiographs of individual 3. At age 6 years, there is moderate platyspondyly. At age 15, the end plates
have a marked concave conformation.
Individual 5 is the older sister of individual 6. According to the birth date declared at immigration,
she would be 10 years old. However, we doubt the accuracy of this date and suspect that she is older
than the stated age. Birth parameters have not been recorded. Her growth parameters were as follows:
height 131.5 cm (−1 SD for age 10), weight 29 kg (−0.81 SD for age 10), and head circumference 51.5 cm
(−0.55 SD for age 10). Shortly after she was referred, she had menarche and her growth has slowed
down significantly. She had protruding eyes and a large forehead, but her facial appearance was
less conspicuous than that of her brother or other affected individuals. She had myopia, and four
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incisor teeth were missing. Intelligence and hearing were normal. She had long tapering fingers and
her interphalangeal joints were hyperextensible. The skin was thin and wrinkled, particularly on the
palmar side of her hands and feet.
3. Results
Figure 1 shows some clinically relevant clinical and radiographic features in SLC39A13-deficient
individuals.
Table 1 shows the genetic variants identified in SLC39A13. Of note, the variants were homozygous
in all patients, underlining the rarity of the disorder.
Figure 2 shows the results of the automated DeepGestalt technology. Both comparisons (SLC39A13
group vs. control group 1, and SLC39A13 group vs. control group 2) gave highly significant results
(AUC= 0.991 p = 0.006 and AUC= 0.986 p = 0.004).
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Figure 2. DeepGestalt technology analysis of facial features in SLC39A13 deficiency. The upper part
shows the “averaged” artificial composite facial gestalt image of individuals with SLC39A13 deficiency
(panel A) vs. two matched control groups (panels B and C). The lower part shows the result of the
comparisons between A vs. B, and A vs. C.
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Figure 3 shows the ratio of the collagen crosslink derivates, pyridinoline and deoxypyridinoline,
in the urine of five patients and five roughly age-matched controls. The ratio of pyridinoline-to-
deoxypyridinoline is reduced in the SLC39A13-deficient subjects, indicating a relative deficiency of the
hydroxylated form, pyridinoline, relative to the non-hydroxylated form, deoxypyridinoline. The values
clearly segregated in two distinct clusters with no overlap. In addition to confirming the notion of
reduced lysyl hydroxylation as a pathogenic mechanism in these patients, the findings show that
determination of urinary crosslink derivates can be a useful diagnostic screening method. Anecdotally,
because of the role of vitamin C in collagen hydroxylation, individuals 1 and 2 took an oral dose of
1000 mg of vitamin C over four weeks and sent us urine samples for analysis before and twice during
the test period. Unfortunately, there was no change in the pyridinoline-to-deoxypyridinoline ratio.
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five SLC39A3-dificient individuals and in five roughly age-matched controls. The ratio is consistently
lower in SLC39A13-deficient individuals, with no overlap to the control group.
4. Discussion
4.1. Clinical Aspects of SCL39A13 Deficiency
Our observations confirm the previous findings of Giunta et al. (2008), Fukada et al. (2008), and
Dusanic et al. (2018) that SLC39A13 d ficiency is associated with a c inical phenotype ch racterized by
po t- atal short stature, connective tissue weakne affecting mainly the skin and ripheral joints,
a characteristic facial appearance, and a mod rat s eletal dysplasia. These addit on l obs vations
help to deline te a more precise henotype.
Muscular hyp ton a—This has been s en in several SLC39A13 patients in the neonatal period
and in early childh od; in the patient described by Dusanic et al. (2018), muscular hypo onia was
conspicuous enough to lead to investigations for myopathy with some abnor al (though n n-specific)
findings in a muscle bi psy at adolescence. While the prev lence of my pathy in SLC39A3 deficiency
and its structural features remain to be investigated, the obser tions confirm t e well-known
phenomeno that connective tissue dise ses, and particularly EDS type VI-A (lysyl hydroxylase
deficiency), may present as the “floppy infant” phenomenon and/or with hypotonia with delayed
motor development.
Growth and statur — ost atal reduced linear growth seems to be a salient and consistent feature
of SLC39A13 deficiency; this is i contrast to other types of conn ctive tissue disease EDS types,
where short stature is not a prom nent featu e. The wo oth r forms of “spondylo ysplastic EDS”,
namely B3GALT6 deficiency and B4GALT7 deficiency, ar als associated with h rt stature, but n
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those conditions, short stature can be explained by skeletal dysplasia. In SLC39A13, body proportions
are normal and short stature seems to be more intrinsic and represents a true growth failure and not a
consequence of bone dysplasia.
Eye findings—Myopia has been reported in several SLC39A13 patients and also seems to be a
direct (though non-specific) manifestation of the primary genetic defect. This may be connected to
the thin sclerae that often have a blueish or greyish color, particularly in individuals with darker
pigmentation. Keratoconus, as seen in three patients, is potentially dangerous because of the possibility
of perforation or rupture; ophthalmologic investigation should be recommended in all confirmed cases.
Dental features—Absence of one or several incisor teeth in the permanent dentition has been
observed in a majority of SLC39A13-deficient individuals. In our case 6, the lower incisors of the
primary dentition were also small and dysplastic. Hypodontia and oligodontia are consistent, if perhaps
not obligate, features of the disorder.
Vascular complications—marked varicosities of the lower legs have been described in a number
of SLC39A13 patients. Clinically, more importantly, the two elder patients known (patients 1 and 2 in
Fukada et al. (2008) and in this study) have both suffered cerebral hemorrhage. While this may not be
statistically significant and may even be causally unrelated (e.g., hormonal contraception in patient 2),
it is worth keeping in mind as a potential complication. Fortunately, other major vascular events have
thus far not been recorded.
Facial features—analysis of the facial features with the DeepGestalt technology and comparison
with age-matched controls confirms that there is an SLC39A13-associated facial phenotype that is
significantly divergent from that of control individuals. This phenotype includes a rather flat face,
mild hypertelorism, downslanting palpebral fissures, lack of periocular connective tissue giving the
impression of prominent eyes, and a small mouth. The Face2Gene system evoked a few other syndromes
with some resemblance to the SLC39A13 phenotype, such as Noonan syndrome (downslanting
palpebral fissures), Stickler syndrome (flat face; associated with COL2A1 haploinsufficiency), as well
as—interestingly—the vascular type of EDS (EDS IV; dominant COL3A1), probably because of the
“hollow eyes”. Thus, analogy between SLC39A13 deficiency and vascular EDS may include vascular
fragility as well as a moderate resemblance of facial features.
4.2. What Are the Pathogenetic Mechanisms Leading from SLC39A13 Loss of Function to the Complex
Clinical Phenotype?
The pathogenesis of SLC39A13 deficiency remains poorly understood. The observation of reduced
collagen hydroxylation indicates that a partial failure of collagen crosslinking is one pathogenic
mechanism [4], and the determination of pyridinoline-to-deoxypyridinoline is a useful diagnostic
help. As correctly indicated by Giunta et al. (2008), the hydroxylation defect probably involves
collagens other than collagen 1, such as collagen 2 and collagen 3, and this may explain the mild
chondrodysplastic features (collagen 2) as well as the thin and fragile skin and the putative vascular
fragility (collagen 3). However, it is difficult to ascribe the short stature, facial features, and oligodontia
solely to reduced collagen hydroxylation. The hypothesis that part of the pathogenesis may involve
the role of zinc as an intracellular messenger [5] may be justified, but experimental evidence is lacking;
in particular, SLC39A13 individuals do not show signs of immune system dysfunction in contrast with
the mouse model [5,11].
4.3. Diagnosis
From the diagnostic perspective, presentation with short stature and dysmorphic facial features
may lead pediatricians and clinical geneticists to classify these patients within the group of genetic
syndromes rather than connective tissue disorders; this “syndromic” presentation of SLC39A13 is not
well known and this report may help raise awareness of this condition and its presenting features
among clinical geneticists and dysmorphologists.
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